vimarsana.com
Home
Live Updates
Pooled Analysis Supports Bioequivalence Between MB02 and Reference Bevacizumab : vimarsana.com
Pooled Analysis Supports Bioequivalence Between MB02 and Reference Bevacizumab : vimarsana.com
Pooled Analysis Supports Bioequivalence Between MB02 and Reference Bevacizumab
In a new pooled analysis of 3 pharmacokinetic studies, the investigators confirmed the bioequivalence, safety, and immunogenicity between biosimilar MB02 and European Union approved bevacizumab and US-approved bevacizumab.
Related Keywords
Spain ,
Japan ,
Madrid ,
United States ,
Japanese ,
,
Abxience Research ,
European Union ,
New England Journal ,
Body Mass Index ,
Medical Department ,
European Union Approved ,
Biosimilar ,
Biosimilars ,
Mb02 ,
Bevacizumab ,
Bioequivalence ,
Cancer Treatment ,
Pooled Analysis ,